Publications by authors named "Jean Chevaleyre"

Claim this Profile
A
An Injectable Solution for Preservation of Hematopoietic Stem and Progenitors Cells in Hypothermic Condition.
Jean Chevaleyre, Laura Rodriguez, Esther Attebi, Pascale Duchez, Zoran Ivanovic

Stem Cell Rev Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discarded plasma obtained after cord blood volume reduction as an alternative for fetal calf serum in mesenchymal stromal cells cultures.
Marija Vlaski-Lafarge, Jean Chevaleyre, Julie Cohen, Zoran Ivanovic, Xavier Lafarge

Transfusion· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia/hypercapnia prevents iron-dependent cold injuries in cord blood stem and progenitor cells.
Sandie Gerby, Mathias Simplicien, Pascale Duchez, Jean Chevaleyre, Zoran Ivanovic

Cytotherapy· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repopulating hematopoietic stem cells from steady-state blood before and after culture are enriched in the CD34CD133CXCR4 fraction.
Véronique Lapostolle, Jean Chevaleyre, Pascale Duchez, Laura Rodriguez, Marija Vlaski-Lafarge

Haematologica· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steady state peripheral blood provides cells with functional and metabolic characteristics of real hematopoietic stem cells.
Antonin Bourdieu, Maryse Avalon, Véronique Lapostolle, Sadek Ismail, Margaux Mombled, Jean Chevaleyre

J Cell Physiol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence.
Angela Ianniciello, Pierre-Yves Dumas, Claire Drullion, Amélie Guitart, Arnaud Villacreces, Jean Chevaleyre

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-scale validation of a new efficient procedure for cryopreservation of ex vivo expanded cord blood hematopoietic stem and progenitor cells.
Pascale Duchez, Laura Rodriguez, Jean Chevaleyre, Philippe Brunet De La Grange, Zoran Ivanovic

Cytotherapy· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 enhances the activity of in vivo long-term reconstituting hematopoietic stem cells in "hypoxic-like" expansion cultures ex vivo.
Pascale Duchez, Laura Rodriguez, Jean Chevaleyre, Veronique Lapostolle, Marija Vlaski

Transfusion· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia/hypercapnia-induced adaptation maintains functional capacity of cord blood stem and progenitor cells at 4°C.
Marija Vlaski, Luc Negroni, Milica Kovacevic-Filipovic, Christelle Guibert, Philippe Brunet de la Grange, Jean Chevaleyre

J Cell Physiol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel procedure to improve functional preservation of hematopoietic stem and progenitor cells in cord blood stored at +4°c before cryopreservation.
Jean Chevaleyre, Laura Rodriguez, Pascale Duchez, Marie Plainfossé, Bernard Dazey

Stem Cells Dev· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Busulfan administration flexibility increases the applicability of scid repopulating cell assay in NSG mouse model.
Jean Chevaleyre, Pascale Duchez, Laura Rodriguez, Marija Vlaski, Arnaud Villacreces

PLoS One· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional stability (at +4°C) of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells.
Pascale Duchez, Jean Chevaleyre, Philippe Brunet de la Grange, Marija Vlaski, Jean-Michel Boiron

Cell Transplant· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive setup of clinical scale procedure for ex vivo expansion of cord blood hematopoietic cells for transplantation.
Pascale Duchez, Jean Chevaleyre, Marija Vlaski, Bernard Dazey, Noel Milpied

Cell Transplant· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells.
Pascale Duchez, Jean Chevaleyre, Philippe Brunet de la Grange, Marija Vlaski, Jean-Michel Boiron

Transfusion· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discarded leukoreduction filters: a new source of stem cells for research, cell engineering and therapy?
Yann Peytour, Arnaud Villacreces, Jean Chevaleyre, Zoran Ivanovic, Vincent Praloran

Stem Cell Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term repopulating hematopoietic stem cells and "side population" in human steady state peripheral blood.
Philippe Brunet de la Grange, Marija Vlaski, Pascale Duchez, Jean Chevaleyre, Veronique Lapostolle

Stem Cell Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-preconditioned mesenchymal stromal cells improve cardiac function in a swine model of chronic myocardial ischaemia.
Jeremie Jaussaud, Matthieu Biais, Joachim Calderon, Jean Chevaleyre, Pascale Duchez

Eur J Cardiothorac Surg· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of low O(2) concentration and mesenchymal stromal cells during culture of cord blood CD34(+) cells improves the maintenance and proliferative capacity of hematopoietic stem cells.
Mohammad Hammoud, Marija Vlaski, Pascale Duchez, Jean Chevaleyre, Xavier Lafarge

J Cell Physiol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-scale cultures of cord blood CD34(+) cells to amplify committed progenitors and maintain stem cell activity.
Zoran Ivanovic, Pascale Duchez, Jean Chevaleyre, Marija Vlaski, Xavier Lafarge

Cell Transplant· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombopoietin to replace megakaryocyte-derived growth factor: impact on stem and progenitor cells during ex vivo expansion of CD34+ cells mobilized in peripheral blood.
Pascale Duchez, Jean Chevaleyre, Marija Vlaski, Bernard Dazey, Fontanet Bijou

Transfusion· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obtaining of CD34+ cells from healthy blood donors: development of a rapid and efficient procedure using leukoreduction filters.
Yann Peytour, Amélie Guitart, Arnaud Villacreces, Jean Chevaleyre, Francis Lacombe

Transfusion· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo.
Marija Vlaski, Xavier Lafarge, Jean Chevaleyre, Pascale Duchez, Jean-Michel Boiron

Exp Hematol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low O2 concentrations enhance the positive effect of IL-17 on the maintenance of erythroid progenitors during co-culture of CD34+ and mesenchymal stem cells.
Aleksandra Krstić, Marija Vlaski, Mohammad Hammoud, Jean Chevaleyre, Pascale Duchez

Eur Cytokine Netw· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-blood leuko-depletion filters as a source of CD 34+ progenitors potentially usable in cell therapy.
Zoran Ivanovic, Pascale Duchez, Doris A Morgan, Francis Hermitte, Xavier Lafarge, Jean Chevaleyre

Transfusion· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis